A case of chronic myelogenous leukemia with e8a2 fusion transcript

Cancer Genetics and Cytogenetics

Volumn 185, Issue 2, 2008, Pages 106-108

  Park, Il Joong ^a   Lim, Young Ae ^a   Lee, Wee Gyo ^a   Park, Joon Seong ^a   Kim, Hugh Chul ^a   Lee, Hyeon Ji ^b   Cho, Sung Ran ^a  

^a Ajou University School of Medicine   (South Korea)

^b Seegene Institute of Life Sciences   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; IMATINIB; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E8A2;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CASE REPORT; CHROMOSOME BAND; CHRONIC MYELOID LEUKEMIA; FUSION GENE; GENE INSERTION; GENE REARRANGEMENT; HUMAN; INTRON; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TREATMENT DURATION; TREATMENT OUTCOME;

GENE FUSION; GENE REARRANGEMENT; GENES, ABL; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 49649101505     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2008.06.001     Document Type: Article

References (17)

1. Rowley J.D. Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243 (1973) 290-293
2. Kurzrock R., Gutterman J.U., and Talpaz M. The molecular genetics of Philadelphia chromosome-positive leukemias. N Engl J Med 319 (1988) 990-998
3. Hochhaus A., Reiter A., Skladny H., Melo J.V., Sick C., Berger U., Guo J.Q., Arlinghaus R.B., Hehlmann R., Goldman J.M., and Cross N.C. A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia. Blood 88 (1996) 2236-2240
4. Sugimoto T., Ijima K., Hisatomi H., Murayama T., Mizuno I., Hato A., Imoto S., Nishimura R., and Koizumi T. Second case of CML with aberrant BCR-ABL fusion transcript (e8/a2) with insertion of an inverted ABL intron 1b sequence. Am J Hematol 77 (2004) 164-166
5. Demehri S., Paschka P., Schultheis B., Lange T., Koizumi T., Sugimoto T., Branford S., Lim L.C., Kegel T., Martinelli G., Hochhaus A., Druker B.J., and Deininger M.W. e8a2 BCR-ABL: more frequent than other atypical BCR-ABL variants?. Leukemia 19 (2005) 681-684
6. Branford S., Rudzki Z., and Hughes T.P. A novel BCR-ABL transcript (e8a2) with the insertion of an inverted sequence of ABL intron 1b in a patient with Philadelphia-positive chronic myeloid leukaemia. Br J Haematol 109 (2000) 635-637
7. Cayuela J.M., Rousselot P., Nicolini F., Espinouse D., Ollagnier C., Bui-Thi M.H., Chabane K., Raffoux E., Callet-Bauchu E., Tigaud I., Magaud J.P., and Hayette S. Identification of a rare e8a2 BCR-ABL fusion gene in three novel chronic myeloid leukemia patients treated with imatinib. Leukemia 19 (2005) 2334-2336
8. Leibundgut E.O., Jotterand M., Rigamonti V., Parlier V., Muhlematter D., Tobler A., and Solenthaler M. A novel BCR-ABL transcript e2a2 in a chronic myelogenous leukaemia patient with a duplicated Ph-chromosome and monosomy 7. Br J Haematol 106 (1999) 1041-1044
9. Roman J., Parziale A., Gottardi E., De Micheli D., Cilloni D., Tiribelli M., Gonzalez M.G., del Carmen Rodriguez M., Torres A., and Saglio G. Novel type of BCR-ABL transcript in a chronic myelogenous leukaemia patient relapsed after bone marrow transplantation. Br J Haematol 111 (2000) 644-646
10. Moreno M del P., Cortinas M.N., Bonomi R., Cardeza A., and Uriarte M del R. A novel BCR-ABL fusion transcript (e15a2) in 2 patients with atypical chronic myeloproliferative syndrome. Blood 97 (2001) 3668-3669
11. Pane F., Frigeri F., Sindona M., Luciano L., Ferrara F., Cimino R., Meloni G., Saglio G., Salvatore F., and Rotoli B. Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction). [Erratum in: Blood 1997;89:4244]. Blood 88 (1996) 2410-2414
12. Rotoli B., Pane F., Salvatore F., and Saglio G. The e19a2 bcr/abl breakpoint in acute lymphoblastic leukaemia. Br J Haematol 110 (2000) 493-496
13. Roman J., Jimenez A., Barrios M., Castillejo J.A., Maldonado J., and Torres A. E1A3 as a unique, naturally occurring BCR-ABL transcript in an indolent case of chronic myeloid leukaemia. Br J Haematol 114 (2001) 635-637
14. Snyder D.S., McMahon R., Cohen S.R., and Slovak M.L. Chronic myeloid leukemia with an e13a3 BCR-ABL fusion: benign course responsive to imatinib with an RT-PCR advisory. Am J Hematol 75 (2004) 92-95
15. Melo J.V. BCR-ABLgene variants. Baillieres Clin Haematol 10 (1997) 203-222
16. Burmeister T., and Reinhardt R. A multiplex PCR for improved detection of typical and atypical BCR-ABL fusion transcripts. Leuk Res 32 (2008) 579-585
17. Tchirkov A., Couderc J.L., Périssel B., Goumy C., Regnier A., Uhrhammer N., Verrelle P., and Berger M. Major molecular response to imatinib in a patient with chronic myeloid leukemia expressing a novel form of e8a2 BCR-ABL transcript. Leukemia 20 (2006) 167-168